Development of HIV with Drug Resistance after CD4 Cell Count--Guided Structured Treatment Interruptions in Patients Treated with Highly Active Antiretroviral Therapy after Dual--Nucleoside Analogue Treatment.

MLA

Nuesch, Reto, et al. “Development of HIV with Drug Resistance after CD4 Cell Count--Guided Structured Treatment Interruptions in Patients Treated with Highly Active Antiretroviral Therapy after Dual--Nucleoside Analogue Treatment.” Clinical Infectious Diseases, vol. 40, no. 5, Mar. 2005, pp. 728–34. EBSCOhost, https://doi.org/10.1086/427878.

APA

Nuesch, R., Ananworanich, J., Sirivichayakul, S., Ubolyam, S., Sianqphoe, U., Hill, A., Cooper, D., Lange, J., Phanuphak, P., & Ruxrungtham, K. (2005). Development of HIV with Drug Resistance after CD4 Cell Count--Guided Structured Treatment Interruptions in Patients Treated with Highly Active Antiretroviral Therapy after Dual--Nucleoside Analogue Treatment. Clinical Infectious Diseases, 40(5), 728–734. https://doi.org/10.1086/427878

Chicago

Nuesch, Reto, Jintanat Ananworanich, Sunee Sirivichayakul, Sasiwimol Ubolyam, Umaporn Sianqphoe, Andrew Hill, David Cooper, Joep Lange, Praphan Phanuphak, and Kiat Ruxrungtham. 2005. “Development of HIV with Drug Resistance after CD4 Cell Count--Guided Structured Treatment Interruptions in Patients Treated with Highly Active Antiretroviral Therapy after Dual--Nucleoside Analogue Treatment.” Clinical Infectious Diseases 40 (5): 728–34. doi:10.1086/427878.